拉丁美洲乳腺活检针市场 – 行业趋势及 2031 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

拉丁美洲乳腺活检针市场 – 行业趋势及 2031 年预测

  • Medical Devices
  • Upcoming Report
  • Mar 2024
  • Country Level
  • 350 页面
  • 桌子數: 220
  • 图号: 60

>拉丁美洲乳腺活检针市场,按针类型(细针抽吸和芯针)、人体工程学(锐针、钝针、Quincke 针、Chiba 针、Franseen 针和其他针)、程序(细针抽吸活检、芯针活检、真空辅助活检和图像引导活检)、可用性(一次性和可重复使用针)、应用(早期癌症筛查、治疗选择、治疗监测和复发监测)、最终用户(医院、诊断中心、活检实验室、门诊手术中心、学术和研究组织等)、分销渠道(直接招标和零售销售)划分 - 行业趋势和预测到 2031 年。

拉丁美洲乳腺活检针市场分析及规模

乳房活检针市场涵盖各种活检技术,包括细针抽吸活检、芯针活检、真空辅助活检和图像引导活检。细针抽吸活检涉及提取细胞进行细胞学评估。芯针活检检索组织样本进行组织学检查。真空辅助活检采用抽吸来增强组织检索,而图像引导活检利用成像方式进行精确的组织定位,共同促进对乳房异常的准确诊断。

Data Bridge Market Research 分析,拉丁美洲乳腺活检针市场在 2023 年的规模为 2225 万美元,预计到 2031 年将达到 4028 万美元,在 2024 年至 2031 年的预测期内,复合年增长率为 7.7%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分      

报告指标

细节

预测期

2024-2031

基准年

2023

历史岁月

2022 (可定制为 2016-2021)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

(细针抽吸和芯针)、人体工程学(锐针、钝针、Quincke 针、Chiba 针、Franseen 针及其他针)、程序(细针抽吸活检、芯针活检、真空辅助活检和图像引导活检)、可用性(一次性和可重复使用型)、应用(早期癌症筛查、治疗选择、治疗监测和复发监测)、最终用户(医院、诊断中心、活检实验室、门诊手术中心、学术和研究组织及其他)、分销渠道(直接招标和零售销售) 

覆盖国家

美国、墨西哥、巴西、阿根廷、哥伦比亚、智利、秘鲁、乌拉圭、玻利维亚和拉丁美洲其他地区。

涵盖的市场参与者

Medax SRL(意大利)、Cook(美国)、BD(美国)、AprioMed AB(瑞典)、INRAD Inc.(美国)、Hologic, Inc.(美国)、Möller Medical GmbH(德国)、IZI Medical Products(美国)、Merit Medical Systems, Inc.(美国)、ADRIA MEDICAL(法国)、Devicor Medical Products Inc.(美国)、Remington Medical Inc.(美国)、PAJUNK GmbH(德国)

市场机会

  • 全球乳腺癌发病率上升
  • 人工智能集成用于活检指导

市场定义

乳房活检针是一种用于从乳房中提取组织样本进行诊断评估的医疗器械。它通常由一根带有切割刃或真空装置的中空细管组成,可以精确瞄准和取出组织进行分析,有助于检测和诊断乳房异常。

拉丁美洲乳腺活检针市场动态

驱动程序

  • 技术创新增强活检针功效

技术进步包括开发更锋利、更精确的针头和成像技术,如超声和 MRI 引导活检,从而提高诊断准确性和患者舒适度。通过提供更好的采样质量和缩短手术时间,这些创新满足了对微创活检程序日益增长的需求。因此,乳腺活检针市场主要由旨在提高活检针功效和患者治疗效果的技术的不断发展所驱动。

  • 人口老龄化导致活检率上升

随着年龄的增长,乳房异常和癌症的发病率不断上升,因此需要更频繁地进行活检等诊断程序。这种人口趋势意味着对乳房活检针的需求增加。因此,制造商正在通过开发先进的活检设备来满足这种日益增长的需求。因此,人口老龄化对活检率的影响成为塑造乳房活检针市场的关键驱动因素。

机会

  • 全球乳腺癌发病率上升

随着乳腺癌发病率的上升,人们对精确诊断工具的需求也日益增长,以便于早期发现和治疗。乳腺活检针在获取组织样本进行组织学检查、帮助精确诊断和制定治疗计划方面发挥着至关重要的作用。对活检针的需求不断增长,凸显了乳腺癌诊断和管理方面市场增长和创新的机会。

  • 人工智能集成用于活检指导

AI-driven systems can enhance biopsy accuracy by providing real-time guidance, improving targeting precision, and reducing procedural errors. By leveraging AI algorithms for image analysis and biopsy planning, healthcare providers can streamline biopsy procedures, leading to quicker diagnoses and improved patient outcomes. This integration not only enhances biopsy efficiency but also opens avenues for innovative AI-driven solutions, shaping the future of breast cancer diagnosis.

Restraints/Challenges

  • Lack of Skilled Healthcare Professionals Performing Biopsies

The lack of skilled healthcare professionals reduces the frequency and quality of biopsies conducted, delaying or preventing timely detection and treatment of breast abnormalities. Additionally, the shortage of skilled personnel may lead to increased wait times for biopsy appointments, causing anxiety and frustration for patients. Consequently, the market faces challenges in expanding its reach and achieving optimal utilization of biopsy technologies in breast cancer diagnosis and management.

  • High Costs Associated with Biopsy Procedures

The elevated expenses may deter individuals from undergoing biopsy examinations, leading to delayed diagnoses and treatment interventions. Moreover, healthcare providers may face financial constraints in procuring advanced biopsy needle technologies, hindering technological advancements and innovation within the market.

This Latin America breast biopsy needle market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Latin America breast biopsy needle market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In May 2023, Argon Medical Devices introduced the SuperCore Advantage Semi-Automatic Biopsy Instrument, a new addition to the biopsy needle market. This innovative device aims to improve biopsy procedures with enhanced efficiency and precision, potentially offering healthcare professionals advanced tools to enhance diagnostic accuracy and patient outcomes
  • In April 2021, AprioMed extended its collaboration with Cenova, aiming to bolster its foothold in the South American market. This strategic alliance may enhance their presence and offerings in the breast biopsy needle market, potentially enabling AprioMed to capitalize on emerging opportunities and meet the region's healthcare needs more effectively
  • 2021 年 2 月,Hologic Inc 收购了 biotheranostics,标志着该公司进入不断扩大的肿瘤学市场,包括乳腺癌。这一战略举措增强了其在癌症诊断方面的网络和能力,可能通过增加创新和市场占有率使其在乳腺活检针市场的产品受益

拉丁美洲乳腺活检针市场范围

拉丁美洲乳腺活检针市场根据针类型、人体工程学、程序、可用性、应用、最终用户和分销渠道进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

针型

  • 细针穿刺
  • 芯针

人类工程学的

  • 锋利的
  • 昆克
  • 千叶
  • 弗兰森
  • 其他的

程序

  • 细针穿刺活检
  • 芯针活检
  • 真空辅助活检
  • 图像引导活检

可用性

  • 一次性的
  • 可重复使用的

 应用

  • 早期癌症筛查
  • 治疗选择
  • 治疗监测
  • 复发监测

最终用户

  • 医院
  • 诊断中心
  • 活检实验室
  • 门诊手术中心
  • 学术及研究机构
  • 其他的

分销渠道

  • 直接招标
  • 零售销售

拉丁美洲乳腺活检针市场区域分析/见解

对拉丁美洲乳房活检针市场进行了分析,并根据上述针类型、人体工程学、程序、可用性、应用、最终用户和分销渠道提供了市场规模洞察和趋势。

拉丁美洲乳腺活检针市场报告涉及的国家包括美国、墨西哥、巴西、阿根廷、哥伦比亚、智利、秘鲁、乌拉圭、玻利维亚和拉丁美洲其他地区。

巴西在乳腺活检针市场占据主导地位,这得益于乳腺癌发病率的上升和公众对癌症筛查意识的提高。这为乳腺活检针市场创造了有利的增长环境,因为用于诊断目的的活检针需求激增。

墨西哥是乳腺活检针市场的领军国家,其主要原因是老龄人口不断增长,而老年人更容易患乳腺癌。随着老龄人口的增长,对活检针的需求也随之增加,进一步巩固了该国的市场主导地位。

阿根廷在乳腺活检针市场占据主导地位,源于越来越多地利用人工智能和机器学习来增强诊断程序。这种技术整合促进了更准确、更高效的活检过程,推动了阿根廷的市场领导地位。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

拉丁美洲乳腺活检针市场还为您提供详细的市场分析,包括每个国家在资本设备医疗支出方面的增长、拉丁美洲乳腺活检针市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对拉丁美洲乳腺活检针市场的影响。数据涵盖 2016-2021 年的历史时期。

竞争格局和拉丁美洲乳腺活检针市场份额分析

拉丁美洲乳腺活检针市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对拉丁美洲乳腺活检针市场的关注有关。

拉丁美洲乳房活检针市场的一些主要参与者包括:

  • Medax SRL (意大利)
  • 库克(美国)
  • BD(美国)
  • AprioMed AB(瑞典)
  • INRAD 公司(美国)
  • Hologic, Inc.(美国)
  • Möller Medical GmbH(德国)
  • IZI 医疗产品 (美国)
  • Merit Medical Systems, Inc.(美国)
  • ADRIA MEDICAL(法国)
  • Devicor Medical Products Inc.(美国)
  • 雷明顿医疗公司 (美国)
  • PAJUNK GmbH(德国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

Technological innovations enhancing biopsy needle efficacy & aging population contributing to higher biopsy rates are the growth drivers of the Latin America breast biopsy needle market.
Needle type, ergonomics, procedure, usability, application, end user and distribution channel are the factors on which the Latin America breast biopsy needle market research is based.
Major companies in the Latin America breast biopsy needle market are Medax SRL (Italy), Cook (U.S.), BD (U.S.), AprioMed AB (Sweden), INRAD Inc. (U.S.), Hologic, Inc. (U.S.), Möller Medical GmbH (Germany), IZI Medical Products (U.S.), Merit Medical Systems, Inc. (U.S.), ADRIA MEDICAL (France), Devicor Medical Products Inc. (U.S.), Remington Medical Inc. (U.S.), PAJUNK GmbH (Germany).
The Latin America breast biopsy needle market size will be worth USD 40.28 million by 2031.
The growth rate of the Latin America breast biopsy needle market is 7.7% in the forecast by 2031.